CAL-101,P110δ抑制剂

CAL-101 (订货以英文为准)

编号:C127044
CAS号:870281-82-6
分子式:C22H18N7OF
分子量:415.42
货号 品牌 包装 目录价 您的价格 库存 数量 购买
C127044-10mg 阿拉丁 10mg ¥166.90
C127044-50mg 阿拉丁 50mg ¥241.90
C127044-500mg 阿拉丁 500mg ¥1284.90
C127044-100mg 阿拉丁 100mg ¥385.90
C127044-250mg 阿拉丁 250mg ¥802.90
产品名称 CAL-101
中文名称 CAL-101,P110δ抑制剂
CAS号 870281-82-6
分子式(M.F.) C22H18N7OF
分子量(M.W.) 415.42
储存条件 -20°C储存
溶解性DMSO 83 mg/mL Water <1 mg/mL Ethanol 35 mg/mL
存贮条件储存温度-20°C
应用A potent PI3K p110δ inhibitor
产品介绍CAL-101 (Idelalisib, GS-1101)是一种选择性p110δ抑制剂,IC50为2.5 nM;作用于p110δ比作用于p110α/β/γ选择性高40到300倍,作用于p110δ比作用于C2β, hVPS34, DNA-PK和mTOR选择性高400到4000倍。Phase 3。
备注CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM; shown to have 40- to 300-fold greater selectivity for p110δ thanp110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR. P
生化机理CAL-101 (GS-1101) is a potent and selective PI3K p110δ inhibitor with an IC50 of 2.5 nM. This compound induces selective cytotoxicity in CLL cells and is independent of IgVH mutational status. CAL--101 also acts as an antagonist in CD40L-mediated CLL cell survival.
别名Idelalisib; GS-1101;5-氟-3-苯基-2-[(1S)-1-(9H-嘌呤-6-基氨基)丙基]-4(3H)-喹唑啉酮;Idelalisib; GS-1101;(S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:252917-06-9
¥ 113.90 C125082-5mg
CAS号:252935-94-7
¥ 735.90 C129718-5mg
CAS号:252917-06-9
¥ 502.90 C129710-5mg
CAS号:1217486-61-7
¥ 109.90 B127311-1mg
CAS号:371935-74-9
¥ 552.90 P125961-10mg
CAS号:1173900-33-8
¥ 627.90 A129523-5mg
CAS号:900185-02-6
¥ 152.90 P129553-1mg
CAS号:915019-65-7
¥ 277.90 B126286-25mg
CAS号:552325-16-3
¥ 1299.90 A126060-5mg